NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences and other industries worldwide, today announced the establishment of a Center of Excellence (“CoE”) at Dr. Christine Vogel’s laboratory at New York University’s Center for Genomics and Systems Biology. As a CoE, the lab will have free use of PBIO’s Barocycler 2320EXTREME (“2320EXT”) primary instrument system through the end of 2020. In addition, the collaboration will offer early access to new, modified, and/or improved versions of the 2320EXT instrument and its associated applications, as well as the opportunity to work closely with PBIO’s senior science and engineering staff on new developments in its pressure-based technology platforms. “We are pleased to have the opportunity to collaborate with Professor Christine Vogel, a well-respected thought leader in proteomics,” PBIO Chief Commercial Officer Dr. Bradford A. Young said in the news release. “We believe the 2320EXT has the potential to support and advance the exciting work that she and her team already have underway at the GSB Center. We further believe that the added exposure received by the PCT platform during the collaboration period will increase awareness of the benefits of our pressure-based technologies in helping to provide scientists with superior proteomic analyses. We believe this added awareness should result in increased products and services revenue in 2019 and beyond.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer